Biomedicines (Jul 2023)

Obesity in Severe COVID-19 Patients Has a Distinct Innate Immune Phenotype

  • Ayane de Sá Resende,
  • Yrna Lorena Matos de Oliveira,
  • Mariana Nobre Farias de Franca,
  • Lucas Sousa Magalhães,
  • Cristiane Bani Correa,
  • Kiyoshi Ferreira Fukutani,
  • Michael Wheeler Lipscomb,
  • Tatiana Rodrigues de Moura

DOI
https://doi.org/10.3390/biomedicines11082116
Journal volume & issue
Vol. 11, no. 8
p. 2116

Abstract

Read online

Obesity alters the capacity of effective immune responses in infections. To further address this phenomenon in the context of COVID-19, this study investigated how the immunophenotype of leukocytes was altered in individuals with obesity in severe COVID-19. This cross-sectional study enrolled 27 ICU COVID-19 patients (67% women, 56.33 ± 19.55 years) that were assigned to obese (BMI ≥ 30 kg/m2, n = 9) or non-obese (BMI 2, n = 18) groups. Monocytes, NK, and both Low-Density (LD) and High-Density (HD) neutrophils were isolated from peripheral blood samples, and surface receptors’ frequency and expression patterns were analyzed by flow cytometry. Clinical status and biochemical data were additionally evaluated. The frequency of monocytes was negatively correlated with BMI, while NK cells and HD neutrophils were positively associated (p p p p < 0.05). Collectively, these outcomes revealed that obesity differentially affected, and largely depressed, innate immune response in severe COVID-19.

Keywords